Myocardial Infarction
|
0.100 |
Biomarker
|
disease |
BEFREE |
This review focuses on post-MI LV ECM remodeling, targeting the discussion on ECM biomarkers that could be useful for predicting MI outcomes.
|
29247693 |
2019 |
Myocardial Infarction
|
0.100 |
Biomarker
|
disease |
BEFREE |
Optimal healing of the myocardium following myocardial infarction (MI) requires a suitable degree of inflammation and its timely resolution, together with a well-orchestrated deposition and degradation of extracellular matrix (ECM) proteins.
|
30524648 |
2018 |
Myocardial Infarction
|
0.100 |
Biomarker
|
disease |
BEFREE |
In this review, we summarize the current literature on the roles of myofibroblasts, MMPs, and ECM proteins in MI-induced LV remodeling.
|
24519465 |
2014 |
Myocardial Infarction
|
0.100 |
GeneticVariation
|
disease |
BEFREE |
Aim of this study was to evaluate the effect of C807T, G873A and T837C polymorphisms of GpIa on modulating platelet function in MI patients on dual antiplatelet treatment undergoing PCI.
|
17157856 |
2008 |
Myocardial Infarction
|
0.100 |
GeneticVariation
|
disease |
BEFREE |
Two silent polymorphisms (807C/T and 873G/A) within glycoprotein Ia (GPIa) gene have been implicated in increased risk of developing thrombosis and myocardial infarction in affected individuals.
|
17164499 |
2007 |
Myocardial Infarction
|
0.100 |
GeneticVariation
|
disease |
BEFREE |
C807T and G1648A polymorphisms affect the density of GPIa on platelet surface, but their effect on the risk for MI and the release of sCD40L is unknown.
|
16697311 |
2006 |
Myocardial Infarction
|
0.100 |
GeneticVariation
|
disease |
BEFREE |
1.To determine the frequency of C807T polymorphism of the GPIa gene in young survivors of myocardial infarction (MI) and 2. to evaluate the relationship between the intensity of CAD in the coronary angiography examination and the 807C/T genetic status of the patients.
|
16136407 |
2005 |
Myocardial Infarction
|
0.100 |
GeneticVariation
|
disease |
BEFREE |
Association of the gene polymorphisms of platelet glycoprotein Ia and IIb/IIIa with myocardial infarction and extent of coronary artery disease in the Korean population.
|
15227729 |
2004 |
Myocardial Infarction
|
0.100 |
GeneticVariation
|
disease |
BEFREE |
None of the 9 polymorphisms of genes encoding proteins involved in coagulation (G-455A beta-fibrinogen: OR, 1.0; CI, 0.8 to 1.2; G1691A factor V: OR, 1.1; CI, 0.6 to 2.1; G20210A factor II: OR, 1.0; CI, 0.5 to 1.9; and G10976A factor VII: OR, 1.0; CI, 0.8 to 1.3), platelet function (C807T glycoprotein Ia: OR, 1.1; CI, 0.9 to 1.3; and C1565T glycoprotein IIIa: OR, 0.9; CI, 0.8 to 1.2), fibrinolysis (G185T factor XIII: OR, 1.2; CI, 0.9 to 1.6; and 4G/5G plasminogen activator inhibitor type 1: OR, 0.9; CI, 0.7 to 1.2), or homocysteine metabolism (C677T methylenetetrahydrofolate reductase: OR, 0.9; CI, 0.8 to 1.1) were associated with an increased or decreased risk of myocardial infarction.
|
12615788 |
2003 |
Myocardial Infarction
|
0.100 |
GeneticVariation
|
disease |
BEFREE |
The T807 allele of the GPIa gene alone or in combination with the PlA2 allele had no major effect on premature myocardial infarction risk.
|
11812069 |
2002 |
Myocardial Infarction
|
0.100 |
GeneticVariation
|
disease |
BEFREE |
The 807T and 873A variants of platelet glycoprotein Ia gene are common and in a perfect linkage in the Japanese population, but it appears unlikely that the 807T (873A) variant represents a useful marker of increased risk for myocardial infarction.
|
11246537 |
2001 |
Myocardial Infarction
|
0.100 |
GeneticVariation
|
disease |
BEFREE |
Association of two silent polymorphisms of platelet glycoprotein Ia/IIa receptor with risk of myocardial infarction: a case-control study.
|
9950439 |
1999 |
Myocardial Infarction
|
0.100 |
GeneticVariation
|
disease |
BEFREE |
Association of the platelet glycoprotein Ia C807T gene polymorphism with nonfatal myocardial infarction in younger patients.
|
10194421 |
1999 |